Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer
Gene replacement therapy is an attractive approach for treatment of genetic disease, but may be complicated by the risk of a neutralizing immune response to the therapeutic gene product. There are examples of humoral and cellular immune responses against the transgene product as well as absence of s...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154443/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12727926/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI16887 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|